Literature DB >> 31323506

A short history of Lassa fever: the first 10-15 years after discovery.

Thomas P Monath1.   

Abstract

This brief review is focused on the events surrounding the initial discovery of a new viral hemorrhagic fever in 1969 and the subsequent 10-15 years during which a substantial understanding of the disease was gained. In 1969, a series of sequential life-threating or fatal infections occurred among health care workers in Nigeria and the laboratory scientist who isolated and characterized the causative agent. The agent, Lassa virus was named after the geographical location of the first recognized human case. The new virus was shown to be related to lymphocytic choriomeningitis and to previously unclassified neotropical viruses, including Argentine and Bolivian hemorrhagic fevers, and a new taxonomic grouping, the Arenaviruses, was proposed. In 1970-72, three further epidemics occurred in Nigeria, Liberia and Sierra Leone, the first two involved nosocomial transmission, and the third was a community-based outbreak, during which the rodent reservoir host was identified. In 1976, a long-term research project commenced in Sierra Leone, which produced a rich body of data from prospectively designed studies on the clinical features, transmission, and treatment of the disease.
Copyright © 2019. Published by Elsevier B.V.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31323506     DOI: 10.1016/j.coviro.2019.06.005

Source DB:  PubMed          Journal:  Curr Opin Virol        ISSN: 1879-6257            Impact factor:   7.090


  5 in total

Review 1.  Common Themes in Zoonotic Spillover and Disease Emergence: Lessons Learned from Bat- and Rodent-Borne RNA Viruses.

Authors:  Evan P Williams; Briana M Spruill-Harrell; Mariah K Taylor; Jasper Lee; Ashley V Nywening; Zemin Yang; Jacob H Nichols; Jeremy V Camp; Robert D Owen; Colleen B Jonsson
Journal:  Viruses       Date:  2021-07-31       Impact factor: 5.048

2.  Immunization with GP1 but Not Core-like Particles Displaying Isolated Receptor-Binding Epitopes Elicits Virus-Neutralizing Antibodies against Junín Virus.

Authors:  Gleyder Roman-Sosa; Anne Leske; Xenia Ficht; Tung Huy Dau; Julia Holzerland; Thomas Hoenen; Martin Beer; Robert Kammerer; Reinhold Schirmbeck; Felix A Rey; Sandra M Cordo; Allison Groseth
Journal:  Vaccines (Basel)       Date:  2022-01-22

3.  Construction and Immunological Evaluation of an Adenoviral Vector-Based Vaccine Candidate for Lassa Fever.

Authors:  Meirong Wang; Ruihua Li; Yaohui Li; Changming Yu; Xiangyang Chi; Shipo Wu; Shulin Liu; Junjie Xu; Wei Chen
Journal:  Viruses       Date:  2021-03-15       Impact factor: 5.048

Review 4.  The Role of Nucleoprotein in Immunity to Human Negative-Stranded RNA Viruses-Not Just Another Brick in the Viral Nucleocapsid.

Authors:  Maja Šantak; Zrinka Matić
Journal:  Viruses       Date:  2022-03-03       Impact factor: 5.048

5.  Space-Time Trends in Lassa Fever in Sierra Leone by ELISA Serostatus, 2012-2019.

Authors:  Jeffrey G Shaffer; John S Schieffelin; Mambu Momoh; Augustine Goba; Lansana Kanneh; Foday Alhasan; Michael Gbakie; Emily J Engel; Nell G Bond; Jessica N Hartnett; Diana K S Nelson; Duane J Bush; Matthew L Boisen; Megan L Heinrich; Megan M Rowland; Luis M Branco; Robert J Samuels; Robert F Garry; Donald S Grant
Journal:  Microorganisms       Date:  2021-03-12
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.